CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ (307,218)	$ (543,690)	$ (762,846)
Adjustments to net income (loss):
Depreciation and amortization	665,072	693,382	853,697
Deferred income tax expense (benefit)	7,335	(10,711)	64,717
Impairments and other charges		72,497	318,582
Amortization of debt discount and deferred financing costs	8,138	21,359	31,238
Losses (gains) on debt buyback	(4,119)	(13,423)	(228,274)
Losses (gains) on long-lived assets, net	7,352	23,864	64,365
Provision (recovery) of bad debt		(2,515)	18,194
Share-based compensation	15,828	19,362	24,638
Foreign currency transaction losses (gains), net	6,689	4,800	13,133
Mark-to-market loss on warrants	95,909
Noncontrolling interest	(43,043)	(25,582)	(42,795)
Other	869	1,298	3,516
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(54,501)	71,805	67,502
Inventory	928	32,037	6,188
Other current assets	3,690	14,166	38,672
Other long-term assets	(11,196)	17,914	20,830
Trade accounts payable and accrued liabilities	61,636	12,143	(142,826)
Income taxes payable	8,616	5,140	(933)
Other long-term liabilities	39,104	34,930	2,163
Net cash provided by (used for) operating activities	501,089	428,776	349,761
Cash flows from investing activities:
Capital expenditures	(373,445)	(234,040)	(195,523)
Proceeds from sales of assets	26,713	124,301	27,397
Other	(21,976)	(7,486)	2,669
Net cash (used for) provided by investing activities	(368,708)	(117,225)	(165,457)
Cash flows from financing activities:
Proceeds from issuance of long-term debt		700,000	1,000,000
Reduction in long-term debt	(182,601)	(186,958)	(1,394,043)
Debt issuance costs	(3,864)	(16,339)	(28,112)
Proceeds from revolving credit facilities	335,000	1,025,000	1,552,500
Reduction in revolving credit facilities	(795,000)	(1,237,500)	(1,235,000)
Dividends to common and preferred shareholders	(65)	(7,380)	(22,538)
Redeemable noncontrolling interest distribution	(10,324)	(58,524)
Distributions to noncontrolling interest	(3,489)	(3,795)	(5,083)
Sale of non-controlling interest - special purpose acquisition company		276,000
Other	(1,189)	(2,083)	(15,725)
Net cash (used for) provided by financing activities	(661,532)	488,421	(148,001)
Effect of exchange rate changes on cash and cash equivalents	(7,219)	(1,742)	(3,061)
Net increase (decrease) in cash and cash equivalents and restricted cash	(536,370)	798,230	33,242
Cash and cash equivalents and restricted cash, beginning of period	1,273,510	475,280	442,038
Cash and cash equivalents and restricted cash, end of period	737,140	1,273,510	475,280
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	991,471	472,246	435,990
Restricted cash, beginning of period	282,039	3,034	6,048
Cash and cash equivalents and restricted cash, beginning of period	1,273,510	475,280	442,038
Cash and cash equivalents, end of period	451,025	991,471	472,246
Restricted cash, end of period	$ 286,115	$ 282,039	$ 3,034
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 737,140	$ 1,273,510	$ 475,280